EMEA-002218-PIP01-17

Key facts

Active substance
Anti-mucosal addressin cell adhesion molecule antibody (SHP647)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0281/2018
PIP number
EMEA-002218-PIP01-17
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Treatment of Crohn's disease
  • Treatment of ulcerative colitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Shire Pharmaceuticals Ireland Limited

Tel. +44 (0)8008 38470
E-mail: medinfoeuceemea@shire.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating